Editas Medicine (EDIT) FCF Margin Growth (1y) (2016 - 2025)
Editas Medicine (EDIT) FCF Margin Growth (1y) (2016 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
5,389.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,525.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Editas Medicine |
262.77 Mn |
262.77 Mn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
9.06 Mn |
| Jun 30, 2025 |
1.04 Mn |
| Mar 31, 2025 |
353,024.00 |
| Dec 31, 2024 |
-10,624.00 |
| Sep 30, 2024 |
-9.03 Mn |
| Jun 30, 2024 |
-1.05 Mn |
| Mar 31, 2024 |
-417,709.00 |
| Dec 31, 2023 |
62,356.00 |
| Sep 30, 2023 |
12.16 Mn |
| Jun 30, 2023 |
-72,296.00 |
| Mar 31, 2023 |
37,846.00 |
| Dec 31, 2022 |
-37,776.00 |
| Sep 30, 2022 |
-12.17 Mn |
| Jun 30, 2022 |
997,990.00 |
| Mar 31, 2022 |
240.00 |
| Dec 31, 2021 |
7,038.00 |
| Sep 30, 2021 |
-56,806.00 |
| Jun 30, 2021 |
-1.02 Mn |
| Mar 31, 2021 |
22,004.00 |
| Dec 31, 2020 |
-71,342.00 |
